MIRIAM RIENSTRA-BAREMAN: Open Payments
NPI 1134748650 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$381 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $65 · 2025 $381
Food & beverage: $282Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $148 |
| Amgen Inc. | 2 | $53 |
| Novo Nordisk Inc | 2 | $44 |
| Lilly USA, LLC | 2 | $34 |
| Indivior Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Corium, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Dexcom, Inc. | 1 | $15 |
Products named: Veozah, EVENITY, SUBLOCADE, Wegovy, SPRAVATO, Azstarys, OTEZLA, QULIPTA.
Industry payments across MI — which companies pay providers there.
